Kangmei Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 1,087.761 million compared to CNY 1,169.797 million a year ago. Operating loss was CNY 601.207 million compared to CNY 317.728 million a year ago. Net loss was CNY 595.231 million compared to CNY 296.629 million a year ago. Basic loss per share from continuing operations was CNY 0.121 compared to CNY 0.06 a year ago.